Anticoagulation and Stroke Prevention
Journal Articles: Pharmacists have a unique role and responsibility in an individual’s care, especially for those with chronic disease. Insights into how pharmacy fellows can be engaged to assess and improve guideline-concordant anticoagulation for atrial fibrillation (AF) were gathered from a quality improvement project sponsored by the Heart Rhythm Society, in collaboration with the University of Florida.
Read MoreJournal Articles: In this issue of Heart Rhythm, we present a new quarterly feature highlighting quality improvement in the delivery of heart rhythm care. These quarterly features will summarize key publications of relevance to the electrophysiology community and provide a forum for recognizing the growing importance of measuring, reporting, and improving the quality of heart rhythm care.
Read MoreTools: Use the updated AnticoagEvaluator to make informed decisions on initiation of antithrombotic therapy for patients with atrial fibrillation (AF) who do not have moderate to severe mitral stenosis or a mechanical heart valve. App updates include expanded advice from the 2019 Focused Update to the 2014 ACC/AHA/HRS Guideline for the Management of Patients with AF.
Read MoreShared Decision-Making: Video demonstrations to support in-person conversations between clinicians and their AFib patients. Includes explanation of normal rhythm vs. AFib, stroke risk, blood thinners, and the WATCHMAN device.
Read MoreEducation – Clinical: Calculates stroke risk for patients with atrial fibrillation, possibly better than the CHADS₂ Score.
Read MoreTools: ManageAnticoag helps clinicians navigate periprocedural planning and bleed management scenarios for patients on oral anticoagulants (OAC).
Read MoreGuidelines/Clinical Documents: Guidelines from CCS to inform best practices for clinicians across all disciplines while treating AFib patients. This document should be an important aid for knowledge translation and a tool to help improve clinical management of this important and challenging arrhythmia.
Read MoreGuidelines/Clinical Documents: Guidelines document outlining best practices for oral anticoagulation in patients with nonvalvular AFib and a CHA2DS2-VASc Score of 1.
Read MoreGuidelines/Clinical Documents: To review the evidence and provide clinical recommendations for the pharmacologic management of atrial fibrillation. Methods: This guideline is based on two systematic reviews of published randomized controlled trials (RCTs) and prospective and retrospective observational studies from 2000 to 2012. An updated literature search was performed to identify new studies from 2012 to December 31, 2015. The targeted audience for the guideline includes all primary care clinicians, and the targeted patient population includes adults who have nonvalvular atrial fibrillation that is not due to a reversible cause. This guideline was developed using a modified version of GRADE to evaluate the quality of the evidence and make recommendations based on the balance of benefits and harms.
Read More